U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. C. R. Bard, Inc. - Close Out Letter 12/16/16
  1. Warning Letters


C. R. Bard, Inc.

C. R. Bard, Inc.



Black HHS-Blue FDA Logo



Los Angeles District
19701 Fairchild Road
Los Angeles, CA 92612 


December 16, 2016

Timothy M. Ring
Chairman and Chief Executive Officer
C.R. Bard Inc.
730 Central Ave.
Murray Hill, NJ 07974

Dear Mr. Ring:

The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter (WL # 27-15), dated 07/13/2015. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


CDR Steven E. Porter, Jr.
Los Angeles District Director

Jason J. Gaede
Vice President, Plant Operations
C.R. Bard, Inc.
289 Bay Road
Queensbury, NY 12804